Change in patient-repOrted outcomes in COPD patients newly initiated on TRIXEO AEROSPHERE in Real worlD

Trial Identifier: D5980R00100
Sponsor: AstraZeneca
NCTID:: NCT06368427
Start Date: April 2024
Primary Completion Date: September 2025
Study Completion Date: September 2025
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Romania Baia Mare, Romania
Romania Bucuresti, Romania
Romania Cluj-Napoca, Romania
Romania Constanta, Romania
Romania Craiova, Romania
Romania Deva, Romania
Romania Dorohoi, Romania
Romania Hunedoara, Romania
Romania Iasi, Romania
Romania Suceava, Romania
Romania Targu Mures, Romania
Romania Timisoara, Romania